182 related articles for article (PubMed ID: 35404047)
1. Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors
Khazan N; Kim KK; Hansen JN; Singh NA; Moore T; Snyder CWA; Pandita R; Strawderman M; Fujihara M; Takamura Y; Jian Y; Battaglia N; Yano N; Teramoto Y; Arnold LA; Hopson R; Kishor K; Nayak S; Ojha D; Sharon A; Ashton JM; Wang J; Milano MT; Miyamoto H; Linehan DC; Gerber SA; Kawar N; Singh AP; Tabdanov ED; Dokholyan NV; Kakuta H; Jurutka PW; Schor NF; Rowswell-Turner RB; Singh RK; Moore RG
J Med Chem; 2022 Apr; 65(8):6039-6055. PubMed ID: 35404047
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.
Khazan N; Quarato ER; Singh NA; Snyder CWA; Moore T; Miller JP; Yasui M; Teramoto Y; Goto T; Reshi S; Hong J; Zhang N; Pandey D; Srivastava P; Morell A; Kawano H; Kawano Y; Conley T; Sahasrabudhe DM; Yano N; Miyamoto H; Aljitawi O; Liesveld J; Becker MW; Calvi LM; Zhovmer AS; Tabdanov ED; Dokholyan NV; Linehan DC; Hansen JN; Gerber SA; Sharon A; Khera MK; Jurutka PW; Rochel N; Kim KK; Rowswell-Turner RB; Singh RK; Moore RG
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444542
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Nuclear Receptor Ligands and Elucidation of Their Mechanisms of Action.
Yamamoto K
Chem Pharm Bull (Tokyo); 2019; 67(7):609-619. PubMed ID: 31257315
[TBL] [Abstract][Full Text] [Related]
4. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
6. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model.
Moore RG; Lange TS; Robinson K; Kim KK; Uzun A; Horan TC; Kawar N; Yano N; Chu SR; Mao Q; Brard L; DePaepe ME; Padbury JF; Arnold LA; Brodsky A; Shen TL; Singh RK
PLoS One; 2012; 7(4):e34443. PubMed ID: 22509304
[TBL] [Abstract][Full Text] [Related]
8. Novel VDR antagonists based on the GW0742 scaffold.
Teske KA; Bogart JW; Arnold LA
Bioorg Med Chem Lett; 2018 Feb; 28(3):351-354. PubMed ID: 29287957
[TBL] [Abstract][Full Text] [Related]
9. 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma.
van Ginkel PR; Yang W; Marcet MM; Chow CC; Kulkarni AD; Darjatmoko S; Lindstrom MJ; Lokken J; Bhattacharya S; Albert DM
J Neurooncol; 2007 Dec; 85(3):255-62. PubMed ID: 17603751
[TBL] [Abstract][Full Text] [Related]
10. A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
Anami Y; Itoh T; Egawa D; Yoshimoto N; Yamamoto K
J Med Chem; 2014 May; 57(10):4351-67. PubMed ID: 24742174
[TBL] [Abstract][Full Text] [Related]
11. Development of Novel Bioluminescent Sensor to Detect and Discriminate between Vitamin D Receptor Agonists and Antagonists in Living Cells.
Mano H; Nishikawa M; Yasuda K; Ikushiro S; Saito N; Takano M; Kittaka A; Sakaki T
Bioconjug Chem; 2015 Oct; 26(10):2038-45. PubMed ID: 26355700
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
[TBL] [Abstract][Full Text] [Related]
13. Distinct Modulation of Wild-Type and Selective Gene Mutated Vitamin D Receptor by Essential Polyunsaturated Fatty Acids.
Balaji H; Selvaraj A; Saha N; Sundar PS; Jubie S; Mohankumar SK
Mini Rev Med Chem; 2021; 21(17):2612-2625. PubMed ID: 33397237
[TBL] [Abstract][Full Text] [Related]
14. 1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.
Washington MN; Weigel NL
Endocrinology; 2010 Apr; 151(4):1409-17. PubMed ID: 20147525
[TBL] [Abstract][Full Text] [Related]
15. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORĪ± and RORĪ³.
Slominski AT; Kim TK; Hobrath JV; Oak ASW; Tang EKY; Tieu EW; Li W; Tuckey RC; Jetten AM
J Steroid Biochem Mol Biol; 2017 Oct; 173():42-56. PubMed ID: 27693422
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
[TBL] [Abstract][Full Text] [Related]
17. Proposal of novel inhibitors for vitamin-D receptor: Molecular docking, molecular mechanics and ab initio molecular orbital simulations.
Nakamura S; Saito R; Yamamoto S; Terauchi Y; Kittaka A; Takimoto-Kamimura M; Kurita N
Biophys Chem; 2021 Mar; 270():106540. PubMed ID: 33418104
[TBL] [Abstract][Full Text] [Related]
18. Structural Analysis of VDR Complex with ZK168281 Antagonist.
Belorusova AY; Chalhoub S; Rovito D; Rochel N
J Med Chem; 2020 Sep; 63(17):9457-9463. PubMed ID: 32787090
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Zinser GM; McEleney K; Welsh J
Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
